TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT05903417 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study NCT05634525 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT06137742 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT06647667 — Predictive Biomarker (PRD): IL1RL1 mRNA
Genes: IL1RL1; DER4; ST2; T1
Study NCT06126029 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05036252 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05939414 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05184491 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study NCT06062420 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT05433753 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05433753 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT04652167 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04652167 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT04652167 — Monitoring Biomarker (MOI): Urokinase plasminogen activator surface receptor
Genes: PLAUR; MO3; UPAR
Study NCT04950725 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06705725 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT04864522 — Predictive Biomarker (PRD): SLAMF7 mRNA
Genes: SLAMF7; CS1; UNQ576/PRO1138
Study NCT06585514 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04988035 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04988035 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT05830838 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study NCT04892498 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT05687058 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04929548 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05923268 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05923268 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04604548 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Mitochondrial DNA
Study NCT05833633 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT06662227 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05034861 — Predictive Biomarker (PRD): FGR mRNA
Genes: FGR; SRC2
Study NCT06132711 — Predictive Biomarker (PRD): TNFSF13 mRNA
Genes: TNFSF13; APRIL; TALL2; ZTNF2; UNQ383/PRO715
Study NCT06132711 — Predictive Biomarker (PRD): TNFSF13B mRNA
Genes: TNFSF13B; BAFF; BLYS; TALL1; TNFSF20; ZTNF4; UNQ401/PRO738
Study NCT04985825 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04985825 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06043024 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05477927 — Predictive Biomarker (PRD): FLT1 mRNA
Genes: FLT1; FLT; FRT; VEGFR1
Study NCT05163249 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT05163249 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04997733 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04675593 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06475781 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT06251453 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT00002032 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06284590 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT06732882 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT05925166 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05664386 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05868174 — Predictive Biomarker (PRD): Carbonic anhydrase IX
Genes: CA9; G250; MN
Study NCT06488495 — Predictive Biomarker (PRD): NTM mRNA
Genes: NTM; IGLON2; NT; UNQ297/PRO337
Study NCT05715996 — Predictive Biomarker (PRD): SPN mRNA
Genes: SPN; CD43
Study NCT05876624 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06419686 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT05843253 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT06558682 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05058976 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06580405 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05963880 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05272683 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT04771468 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05011188 — Predictive Biomarker (PRD): CD46 mRNA
Genes: CD46; MCP; MIC10
Study NCT05622851 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05384262 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT05844787 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06086327 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study NCT04980885 — Predictive Biomarker (PRD): CD47 mRNA
Genes: CD47; MER6
Study NCT06195839 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05885152 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05896566 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05217082 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT04502628 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT05972278 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT05052866 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT04595773 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06093737 — Predictive Biomarker (PRD): COPE mRNA
Genes: COPE
Study NCT06272799 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05673928 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04851925 — Predictive Biomarker (PRD): MYRF mRNA
Genes: MYRF; C11orf9; KIAA0954; MRF
Study NCT05741151 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06071273 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05239351 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05748873 — Predictive Biomarker (PRD): PDE6B mRNA
Genes: PDE6B; PDEB
Study NCT04744051 — Predictive Biomarker (PRD): CCS mRNA
Genes: CCS
Study NCT06010472 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06032936 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05131620 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05959824 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT05974774 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT06526832 — Predictive Biomarker (PRD): Tumor-infiltrating lymphocyte
Study NCT05798533 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT06435130 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05575453 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06620679 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04941599 — Predictive Biomarker (PRD): FH mRNA
Genes: FH
Study NCT04657679 — Predictive Biomarker (PRD): CYP3A5 mRNA
Genes: CYP3A5
Study NCT05543603 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study NCT05997524 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05997524 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05343754 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06379789 — Predictive Biomarker (PRD): F9 mRNA
Genes: F9
Study NCT06379789 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study NCT04828993 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study NCT05514873 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study NCT04680065 — Predictive Biomarker (PRD): GDNF mRNA
Genes: GDNF
Study NCT00002123 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01194349 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06651580 — Predictive Biomarker (PRD): MANF mRNA
Genes: MANF; ARMET; ARP
Study NCT06651580 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT06653699 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04480476 — Predictive Biomarker (PRD): Tripeptidyl-peptidase I
Genes: TPP1; CLN2; GIG1; UNQ267/PRO304
Study NCT05280340 — Safety Biomarker (SAF): Interleukin 1
Study NCT03947437 — Predictive Biomarker (PRD): LEP mRNA
Genes: LEP; OB; OBS
Study NCT04847960 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04847960 — Safety Biomarker (SAF): Interleukin 1
Study NCT04847960 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 1 beta
Genes: IL1B; IL1F2
Study NCT04847960 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04847960 — Predictive Biomarker (PRD): IL6
Genes: IL-6; BSF2; HGF; HSF
Study NCT04847960 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT04847960 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT04579133 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT05300074 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study NCT05009875 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04923399 — Predictive Biomarker (PRD): NPY mRNA
Genes: NPY
Study NCT04985604 — Predictive Biomarker (PRD): RAF1 mRNA
Genes: RAF1; RAF
Study NCT05133297 — Predictive Biomarker (PRD): TLL1 mRNA
Genes: TLL1; TLL
Study NCT04906447 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT05601791 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05601791 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05507541 — Predictive Biomarker (PRD): CD47 mRNA
Genes: CD47; MER6
Study NCT05507541 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT04827628 — Predictive Biomarker (PRD): TJP1 mRNA
Genes: TJP1; ZO1
Study NCT06399666 — Predictive Biomarker (PRD): KLHL17 mRNA
Genes: KLHL17; AF
Study NCT06399666 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05924685 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05291767 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00002184 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04916522 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05394376 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05128734 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT04098354 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06584903 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06651749 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06383520 — Predictive Biomarker (PRD): GPC3 mRNA
Genes: GPC3; OCI5
Study NCT04483076 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT05020288 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT05648526 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT05946278 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05212454 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05212454 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05212454 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05212454 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05285774 — Predictive Biomarker (PRD): S100B mRNA
Genes: S100B
Study NCT06374446 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05098665 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study NCT05713279 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT05713279 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study NCT05713279 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study NCT05713279 — Predictive Biomarker (PRD): JAK3 mRNA
Genes: JAK3
Study NCT05713279 — Predictive Biomarker (PRD): TYK2 mRNA
Genes: TYK2
Study NCT05068518 — Predictive Biomarker (PRD): NTM mRNA
Genes: NTM; IGLON2; NT; UNQ297/PRO337
Study NCT06094426 — Predictive Biomarker (PRD): Tumor-infiltrating lymphocyte
Study NCT05673837 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05031975 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT05031975 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT04480554 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06177158 — Monitoring Biomarker (MOI): Matrix metalloproteinase 8
Genes: MMP8; CLG1
Study NCT06177158 — Pharmacodynamic Biomarker (PDY): Matrix metalloproteinase 9
Genes: MMP9; CLG4B
Study NCT05737186 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT06612645 — Predictive Biomarker (PRD): CD276 mRNA
Genes: CD276; B7H3; PSEC0249; UNQ309/PRO352
Study NCT05708326 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04848675 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05933057 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT05332990 — Pharmacodynamic Biomarker (PDY): High-frequency oscillations
Study NCT00051480 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05270772 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06195709 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06195709 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study NCT05367895 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05690100 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT04878731 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06073054 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04854369 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05473026 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06300580 — Safety Biomarker (SAF): DRD3
Study NCT05267262 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT06147063 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06147063 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06580522 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04908787 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06008886 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT04286568 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04264078 — Predictive Biomarker (PRD): CD7 mRNA
Genes: CD7
Study NCT06389708 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT05625594 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06580977 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT06580977 — Safety Biomarker (SAF): BDNF
Study NCT04711642 — Pharmacodynamic Biomarker (PDY): Matrix metalloproteinase 9
Genes: MMP9; CLG4B
Study NCT06412328 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT04725214 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT05602025 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT00001080 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04742556 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study NCT04742556 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT05286697 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05828303 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT05828303 — Pharmacodynamic Biomarker (PDY): Tropomyosin-related kinase A
Genes: NTRK1; MTC; TRK; TRKA
Study NCT04796623 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04796623 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05548751 — Safety Biomarker (SAF): Hypoxanthine-guanine phosphoribosyltransferase
Genes: HPRT1; HPRT
Study NCT06397131 — Predictive Biomarker (PRD): CNTF mRNA
Genes: CNTF
Study NCT06287723 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05521802 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT06358443 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05766397 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT05811507 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CYP17A1 mRNA
Genes: CYP17A1; CYP17; S17AH
Study NCT05811507 — Predictive Biomarker (PRD): AKR1C3 mRNA
Genes: AKR1C3; DDH1; HSD17B5; KIAA0119; PGFS
Study NCT05811507 — Predictive Biomarker (PRD): SULT2A1 mRNA
Genes: SULT2A1; HST; STD
Study NCT05811507 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HSD3B1 mRNA
Genes: HSD3B1; 3BH; HSDB3A
Study NCT05811507 — Predictive Biomarker (PRD): HSD3B2 mRNA
Genes: HSD3B2; HSDB3B
Study NCT05811507 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT05536024 — Predictive Biomarker (PRD): ATRX mRNA
Genes: ATRX; RAD54L; XH2
Study NCT05536024 — Predictive Biomarker (PRD): TERT mRNA
Genes: TERT; EST2; TCS1; TRT
Study NCT05153200 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06150040 — Safety Biomarker (SAF): Netrin-1
Genes: NTN1; NTN1L
Study NCT05071846 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT05401110 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05401110 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05671107 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT05523011 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT05523011 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06503783 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05062161 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05169437 — Predictive Biomarker (PRD): PALB2 mRNA
Genes: PALB2; FANCN
Study NCT04864509 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05968287 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT05101590 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05467254 — Predictive Biomarker (PRD): Myeloid cell surface antigen CD33
Genes: CD33; SIGLEC3
Study NCT05665036 — Predictive Biomarker (PRD): IDUA mRNA
Genes: IDUA
Study NCT05890352 — Predictive Biomarker (PRD): EZH2 mRNA
Genes: EZH2; KMT6
Study NCT06330480 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04910646 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06433804 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06433804 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT05822453 — Predictive Biomarker (PRD): BTC mRNA
Genes: BTC
Study NCT05629559 — Predictive Biomarker (PRD): AGA mRNA
Genes: AGA
Study NCT05831033 — Predictive Biomarker (PRD): Tumor-infiltrating lymphocyte
Study NCT05054088 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05584241 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT06509217 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06050954 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT04197700 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06125522 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT06486350 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05735860 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05003752 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06124716 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05167851 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05167851 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04778397 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT06235931 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06235931 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT04901351 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06454955 — Predictive Biomarker (PRD): CD276 mRNA
Genes: CD276; B7H3; PSEC0249; UNQ309/PRO352
Study NCT04957316 — Predictive Biomarker (PRD): TLR4 mRNA
Genes: TLR4
Study NCT04782895 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05098613 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05098613 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2